DEA Signals It’s Open To Revising Telehealth Rules, Stakeholders Pitched WH On Changes

The Drug Enforcement Administration recently signaled it was open to changing its widely criticized rule proposed in February that would restrict telehealth prescribing of controlled substances, coming after stakeholders pitched the White House and DEA to change the proposal to increase opportunities for telehealth prescribing, such as through a special registration scheme that DEA had rejected. DEA asserted in its recently issued temporary extension of pandemic telehealth prescribing flexibility that it would work in concert with the Substance Abuse and...